Skip to main content

Table 1 Descriptive Characteristics of Eligible Prostate Cancer Cases Diagnosed at Age 40+ in PCR, 2004–2014

From: Spatial patterns in prostate Cancer-specific mortality in Pennsylvania using Pennsylvania Cancer registry data, 2004–2014

Variables

PA

(N = 94,274)

PA

Catchment Area

Catchment Area

(N = 27,357, 29.02%)

Non-Catchment Area

(N = 66,917, 70.98%)

Rural

Appalachia

(N = 3828, 13.99%)

Urban

Appalachia

(N = 6483, 23.70%)

Urban

Non-Appalachia

(N = 17,046, 62.31%)

Mean Age in years (SD)a,b

66.38 (9.38)

66.73 (9.37)

66.24 (9.38)

66.95 (9.31)

66.47 (9.31)

66.77 (9.40)

Mean Serum PSA, ng/mL (SD) a,b

12.21 (19.03)

12.43 (18.88)

12.12 (19.09)

12.97 (19.83)

13.11 (19.73)

12.04 (18.3)

Missing #

11,963

3667

8296

583

714

2370

Racen (%)a,b

 White

79,066 (83.87)

25,278 (92.40)

53,788 (80.38)

3681 (96.16)

6171 (95.19)

15,426 (90.50)

 Black

10,067 (10.68)

1038 (3.79)

9029 (13.49)

64 (1.67)

126 (1.94)

848 (4.97)

 Asian

571 (0.61)

91 (0.33)

480 (0.72)

3 (0.08)

16 (0.25)

72 (0.42)

 Other/Unknown

4570 (4.85)

950 (3.47)

3620 (5.41)

80 (2.09)

170 (2.62)

700 (4.11)

Ethnicityn (%)a,b

 Hispanic

1309 (1.39)

528 (1.93)

781 (1.17)

25 (0.65)

60 (0.93)

443 (2.60)

 Non-Hispanic

80,271 (85.15)

23,411 (85.58)

56,860 (84.97)

3057 (79.86)

5230 (80.67)

15,124 (88.72)

 Unknown

12,694 (13.47)

3418 (12.49)

9276 (13.86)

746 (19.49)

1193 (18.40)

1479 (8.68)

Insurancen (%)a,b

 Insured

76,737 (81.40)

22,045 (80.58)

54,692 (81.73)

3049 (79.65)

5296 (81.69)

13,700 (80.37)

 Uninsured

443 (0.47)

161 (0.59)

282 (0.42)

24 (0.63)

18 (0.28)

119 (0.70)

 Unknown

17,094 (18.13)

5151 (18.83)

11,943 (17.85)

755 (19.72)

1169 (18.03)

3227 (18.93)

Gleason Scoren (%)a,b

 6

40,762 (43.24)

11,768 (43.02)

28,994 (43.33)

1754 (45.82)

2762 (42.60)

7252 (42.54)

 7

37,531 (39.81)

10,725 (39.20)

26,806 (40.06)

1398 (36.52)

2550 (39.33)

6777 (39.76)

 8–10

15,525 (16.47)

4723 (17.26)

10,802 (16.14)

655 (17.11)

1140 (17.58)

2928 (17.18)

 Unknown

456 (0.48)

141 (0.52)

315 (0.47)

21 (0.55)

31 (0.48)

89 (0.52)

Tumor Stagen (%)b

 T1

37,957 (40.26)

11,118 (40.64)

26,839 (40.11)

1617 (42.24)

2532 (39.06)

6969 (40.88)

 T2

41,341 (43.85)

11,851 (43.32)

29,490 (44.07)

1639 (42.82)

2779 (42.87)

7433 (43.61)

 T3

8539 (9.06)

2477 (9.05)

6062 (9.06)

290 (7.58)

607 (9.36)

1580 (9.27)

 T4

1338 (1.42)

391 (1.43)

947 (1.42)

62 (1.62)

101 (1.56)

228 (1.34)

 Unknown

5099 (5.41)

1520 (5.56)

3579 (5.35)

220 (5.75)

464 (7.16)

836 (4.90)

Distant Metastasisn (%)b

 Yes

3580 (3.80)

1028 (3.76)

2552 (3.81)

165 (4.31)

269 (4.15)

594 (3.48)

 No

82,355 (87.36)

23,468 (85.78)

58,887 (88.00)

3141 (82.05)

5418 (83.57)

14,909 (87.46)

 Unknown

8339 (8.85)

2861 (10.46)

5478 (8.19)

522 (13.64)

796 (12.28)

1543 (9.05)

Aggressivenessn (%)a,b

 Less Aggressive

56,121 (59.53)

15,822 (57.84)

40,299 (60.22)

2217 (57.92)

3646 (56.24)

9959 (58.42)

 More Aggressive

30,931 (32.81)

9078 (33.18)

21,853 (32.66)

1174 (30.67)

2177 (33.58)

5727 (33.60)

 Unknown

7222 (7.66)

2457 (8.98)

4765 (7.12)

437 (11.42)

660 (10.18)

1360 (7.98)

Lymph Node Positiven (%)

 No

81,875 (86.85)

23,458 (85.75)

58,417 (87.30)

3153 (82.37)

5474 (84.44)

14,831 (87.01)

 Yes

2327 (2.47)

642 (2.35)

1685 (2.52)

93 (2.43)

151 (2.33)

398 (2.33)

 Unknown

10,072 (10.68)

3257 (11.91)

6815 (10.18)

582 (15.20)

858 (13.23)

1817 (10.66)

Definitive Treatment Regimenn (%)a,b

 Radiation Only

35,373 (37.52)

10,259 (37.50)

25,114 (37.53)

1294 (33.80)

2357 (36.36)

6608 (38.77)

 Primary Site Surgery Only

31,985 (33.93)

8863 (32.40)

23,122 (34.55)

1070 (27.95)

1954 (30.14)

5839 (34.25)

 Both Treatments Received

1976 (2.10)

580 (2.12)

1396 (2.09)

88 (2.30)

139 (2.14)

353 (2.07)

 Neither Treatment Received

22,707 (24.09)

6783 (24.79)

15,924 (23.80)

1271 (33.20)

1810 (27.92)

3702 (21.72)

 Unknown/Missing

2233 (2.37)

872 (3.19)

1361 (2.03)

105 (2.74)

223 (3.44)

544 (3.19)

  1. Note: 1) Rural refers to Non-Metro (RUCC≥4); Urban refers to Metro (RUCC< 4); 2) All reported percentages are column percentages; 3) PSA = Prostate-Specific Antigen (PCR documentation top-coded at 98.0 and bottom-coded at 0.1); 4) Tumor Stage was based on TNM staging system; 5) Primary Site Surgery refers only to total organ resection (radical prostatectomy not otherwise specified [NOS], total prostatectomy NOS, prostatectomy with resection in continuity with other organs, prostatectomy NOS); 6) Unknown/Missing/Other categories were not included in statistical tests of association; 7) Chi-Square tests are used for categorical characteristics and one-way ANOVA are for continuous characteristics
  2. a Significant difference between the Catchment and Non-Catchment Areas in PA
  3. b Significant associations among Appalachian-RUCC Regions within the Catchment Area